Dannex Ayrton Starwin (Ghana) appoints three new directors to it’s board

By Published On: December 17th, 2021Categories: Corporate announcement

Dannex Ayrton Starwin Plc “DAS PHARMA” announces the appointment of three (3) new directors to its Board. Mr. Kwasi Yirenkyi, Mr. Henry Otu Ocansey and Mr. Benjamin Agyeman are the latest addition to steer the affairs of the company at the Board level.

Please find their profile below:

Mr. Kwasi Yirenkyi

Mr. Kwasi Yirenkyi has served as a Managing Director of Starwin Products Limited between November 2007 and July 2015. Prior to that he was a

Non-Executive Director of the company between March 2005 and November 2007.

He has about 20 years of business operations experience. He previously worked with Merchant Bank Ghana Limited, now Universal Merchant Bank as a senior corporate manager.

He also worked with Deloitte and Touche Consulting Ghana and Empretec Ghana. Kwasi is on the boards of Opportunity International Savings and Loans Limited and the SSNIT Guest House Company Limited.

He is a product of George Mason University and the Southern New Hampshire University, both in the United States of America.

Mr. Henry Otu Ocansey

Mr. Henry Otu Ocansey holds an Executive MBA in Finance, University of Ghana (Legon) and BSc. Admin in (Accounts/Finance) from GIMPA.

Henry joined Dannex in 2000, as a Management Accountant and was appointed Chief Accountant in 2004 and Head of Finance in 2006.

Prior to his joining Dannex Limited, he worked with Pharmaplast Limited initially as a Cost Accountant and later as a Management Accountant.

He is a seasoned, experienced executive in the General Management Field, an Accountant with a background in Commercial, Audit Management and Finance.

Mr, Benjamin Agyeman

Mr. Ben Agyeman has over 25 years of working experience in the financial industry, particularly in Private Equity/Venture Capital, Mergers & Acquisitions and Project Finance in developing markets. He was a Managing Director of MPC Capital AG (Hamburg), a German based global Private Equity manager of real assets, with assets under management of over 4bn euros. He is an expert in equity and structured investments as well as infrastructure transactions. He was a former Investment Director at Gulf Finance House, based in the Kingdom of Bahrain in the Middle East.

Before that, Ben was an Investment Banker at UBS AG and prior to that a Technology Business Analyst at Lehman Brothers International. He is currently a Senior Advisor to Kreen Energy Ltd, UK. He holds an MBA from Columbia Business School in New York, USA and a B.Eng. (Hons) Electronic/Electrical Engineering from London South Bank University in the UK.

The full Board of DAS PHARMA is thus;

  • Mr. Nik Amarteifio – Executive Chairman
  • Mr. Daniel Apeagyei Kissi – Chief Executive Officer
  • Dr. Barima Afrane – Member
  • Madam Amarteokor Amarteifio – Member
  • Mr. Alex Bonney – Member
  • Mr. Kwasi Yirenkyi – Member
  • Mr. Henry Otu Ocansey – Member
  • Mr. Benjamin Agyeman – Member
  • Mr. Kwesi Austin – Secretary

The contents of the post above were obtained from third parties, which We, AfricanFinancials, believe to be reliable. However, We do not guarantee their accuracy and the above information may be in condensed form. The reader is encouraged to refer to the original source of the information, which, in most cases, is in PDF format and on the originating company's letterhead. While We endeavour to replicate the original content accurately, We cannot guarantee the absence of errors in the above article and We disclaim any liability regarding reliance on information provided in this article.